FDgard® Dosage Instructions
FDgard® should be taken as directed by the physician. (Usual adult dosage: two capsules, two times a day. Take 30-60 minutes before meal(s) with water. Do not exceed six capsules per day. Swallow capsules whole or mix contents with applesauce. Do not chew). FDgard® sachets (institutional packs) should be administered by a healthcare provider through a nasogastric or gastrostomy tube.
FDgard® has been formulated to be taken 30-60 minutes before a meal. If this pre-meal dosage is missed, the patients have dosing flexibility to take FDgard® during or after a meal.
In very rare cases, allergic reactions to caraway oil and l-Menthol can occur. Use with caution in patients who have a history of gallstones. Like many other food extracts, there is no chronic use dosing data available on caraway oil and l-Menthol.
Although the SST® technology is designed to eliminate the heartburn and anal burning side effects seen in older delivery technologies,* it would still be advisable to counsel patients to avoid simultaneous intake of acid reducers such as antacids. Note: FDgard® may interact with certain medications (e.g., cyclosporine), affecting how the body can break them down.
For more information, please visit the Frequently Asked Questions page. Also feel free to contact us.
“What I like about FDgard® is it’s very safe, very easy to access...It’s very effective, and I find that it works early on.”
“FDgard® [has] very minimal side effects and is easily accessible over the counter.”
“One will do anything to feel better, so my husband and I went to CVS/pharmacy and luckily found one remaining box on the shelf, I bought it, took it that afternoon and again the next morning. To my surprise and amazement, I felt great within a short time, and continued feeling wonderful.”
* Chey WD, Lacy BE, Cash BD, Epstein M, et al. A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial. Clin Transl Gastroenterol. 2019;10(4) (FDRESTTM, Functional Dyspepsia Response Evaluation and Safety Trial)